Abstract
The Global Initiative for Chronic Obstructive Lung Disease guidelines stated that COPD is a disease of airflow limitation that is associated with abnormal inflammatory response. Targeting inflammation and improving airflow is a central goal to treat this disease. Corticosteroids are currently the most popular anti-inflammatory agents for obstructive airway disease. Several long-acting bronchodilators are available to improve airflow. Suppression of inflammation in the asthmatic airway is associated with an increase of expiratory flow. In COPD, the relation between inflammation and airflow limitation is not as clear as that in asthma. Understanding the characters of inflammation and the pathogenesis of airflow limitation may help to provide optimal treatment for patients with COPD.
Keywords: Neutrophils, anti-inflammatory, corticosteroids, T Lymphocytes, matrix metalloproteases, bronchodilator reversibility
Current Respiratory Medicine Reviews
Title: Airway Inflammation and Airflow Limitation in COPD
Volume: 2 Issue: 4
Author(s): Diahn-Warng Perng, Kang-Cheng Su and Lung-Yu Liu
Affiliation:
Keywords: Neutrophils, anti-inflammatory, corticosteroids, T Lymphocytes, matrix metalloproteases, bronchodilator reversibility
Abstract: The Global Initiative for Chronic Obstructive Lung Disease guidelines stated that COPD is a disease of airflow limitation that is associated with abnormal inflammatory response. Targeting inflammation and improving airflow is a central goal to treat this disease. Corticosteroids are currently the most popular anti-inflammatory agents for obstructive airway disease. Several long-acting bronchodilators are available to improve airflow. Suppression of inflammation in the asthmatic airway is associated with an increase of expiratory flow. In COPD, the relation between inflammation and airflow limitation is not as clear as that in asthma. Understanding the characters of inflammation and the pathogenesis of airflow limitation may help to provide optimal treatment for patients with COPD.
Export Options
About this article
Cite this article as:
Perng Diahn-Warng, Su Kang-Cheng and Liu Lung-Yu, Airway Inflammation and Airflow Limitation in COPD, Current Respiratory Medicine Reviews 2006; 2 (4) . https://dx.doi.org/10.2174/157339806778777267
DOI https://dx.doi.org/10.2174/157339806778777267 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antioxidant Properties of Kalanchoe blossfeldiana – A Focus on Erythrocyte Membrane Stability and Cytoprotection
Current Traditional Medicine The Hippocampal Autophagic Machinery is Depressed in the Absence of the Circadian Clock Protein PER1 that may Lead to Vulnerability During Cerebral Ischemia
Current Neurovascular Research Piperine: Medicinal, Analytical and Therapeutics perspective
Current Bioactive Compounds Polymeric Carrier Systems for siRNA Delivery
Current Topics in Medicinal Chemistry Rhodanine as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry The Potential of Selected Prostanoid Receptors as Targets in a New Therapeutic Strategy for Allergy and Immune Diseases
Current Drug Safety Selective Glucocorticoid Receptor Ligands
Medicinal Chemistry The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Hapten Recognition by T Cells: A Functional and Molecular View
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial [Hot topic: Novel Approaches to Pharmacogenomic Investigations (Executive Editor: Kelan G. Tantisira)]
Current Pharmaceutical Design Aerosol Devices and Asthma Therapy
Current Drug Delivery Role of GATA-3 in Allergic Diseases
Current Molecular Medicine Triggering Receptor Expressed on Myeloid Cells (TREM) Family and the Application of Its Antagonists
Recent Patents on Anti-Infective Drug Discovery Pneumopericardium after Foreign Body Aspiration: A Case Report
New Emirates Medical Journal Editorial [ Advances in Heme Oxygenase Research as a Potential Therapeutic Strategy Executive Editor: M.J. Alcaraz]
Current Pharmaceutical Design In Silico Studies on DARC
Infectious Disorders - Drug Targets Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Current Pharmaceutical Design Patent Selections:
Recent Patents on Food, Nutrition & Agriculture Perinatal Events Affecting the Onset of Allergic Diseases
Current Drug Targets - Inflammation & Allergy Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets